CLN5 Human Gene Knockout Kit (CRISPR)
CAT#: KN414709
CLN5 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated.
KN2.0 knockout kit validation
USD 1,290.00
2 Weeks*
Specifications
Product Data | |
Format | 2 gRNA vectors, 1 linear donor |
Donor DNA | EF1a-GFP-P2A-Puro |
Symbol | CLN5 |
Locus ID | 1203 |
Disclaimer | The kit is designed based on the best knowledge of CRISPR technology. The system has been functionally validated for knocking-in the cassette downstream the native promoter. The efficiency of the knock-out varies due to the nature of the biology and the complexity of the experimental process. |
Reference Data | |
RefSeq | NM_006493, NM_001366624 |
Synonyms | NCL |
Summary | 'This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function.[provided by RefSeq, Oct 2008]' |
Documents
Product Manuals |
FAQs |
Resources
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
KN214709 | CLN5 - human gene knockout kit via CRISPR, HDR mediated |
USD 1,290.00 |
|
KN214709BN | CLN5 - human gene knockout kit via CRISPR, HDR mediated |
USD 1,290.00 |
|
KN214709LP | CLN5 - human gene knockout kit via CRISPR, HDR mediated |
USD 1,290.00 |
|
KN214709RB | CLN5 - human gene knockout kit via CRISPR, HDR mediated |
USD 1,290.00 |
|
GA100859 | CLN5 CRISPRa kit - CRISPR gene activation of human CLN5 intracellular trafficking protein |
USD 1,290.00 |
{0} Product Review(s)
Be the first one to submit a review